The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
A Multifactorial Approach to Hepatobiliary Transporter Assessment Enables Improved Therapeutic Compound Development
Open accessAbstract
The bile salt export pump (BSEP) is expressed at the canalicular domain of hepatocytes, where it serves as the primary route of elimination for monovalent bile acids (BAs) into the bile canaliculi. The most compelling evidence linking dysfunction in BA transport with liver injury in humans is found with carriers of mutations that render BSEP nonfunctional. Based on mounting evidence, there appears to be a strong association between drug-induced BSEP interference and liver injury in humans; however, causality has not been established. For this reason, drug-induced BSEP interference is best considered a susceptibility factor for liver injury as other host- or drug-related properties may contribute to the development of hepatotoxicity. To better understand the association between BSEP interference and liver injury in humans, over 600 marketed or withdrawn drugs were evaluated in BSEP expressing membrane vesicles. The example of a compound that failed during phase 1 human trials is also described, AMG 009. AMG 009 showed evidence of liver injury in humans that was not predicted by preclinical safety studies, and BSEP inhibition was implicated. For 109 of the drugs with some effect on in vitro BSEP function, clinical use, associations with hepatotoxicity, pharmacokinetic data, and other information were annotated. A steady state concentration (C(ss)) for each of these annotated drugs was estimated, and a ratio between this value and measured IC₅₀ potency values were calculated in an attempt to relate exposure to in vitro potencies. When factoring for exposure, 95% of the annotated compounds with a C(ss)/BSEP IC₅₀ ratio ≥ 0.1 were associated with some form of liver injury. We then investigated the relationship between clinical evidence of liver injury and effects to multidrug resistance-associated proteins (MRPs) believed to play a role in BA homeostasis. The effect of 600+ drugs on MRP2, MRP3, and MRP4 function was also evaluated in membrane vesicle assays. Drugs with a C(ss)/BSEP IC₅₀ ratio ≥ 0.1 and a C(ss)/MRP IC₅₀ ratio ≥ 0.1 had almost a 100% correlation with some evidence of liver injury in humans. These data suggest that integration of exposure data, and knowledge of an effect to not only BSEP but also one or more of the MRPs, is a useful tool for informing the potential for liver injury due to altered BA transport.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Considering that mechanisms leading to alterations in bile-acid homeostasis are believed in part to be responsible for recent prominent late-stage clinical attritions and black box warnings of novel therapeutics, including examples such as CP-724,714 (Feng et al. 2009), tolvaptan (Slizgi et al. 2016), AMG-009 (Morgan et al. 2013), and TAK-875 (Wolenski et al. 2017)”
From Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury (2017) · cites this paper as Morgan et al. 2013
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
The 1996 Guide for the Care and Use of Laboratory Animals
Clark, J. D., Gebhart, G. F., Gonder, J. C., Keeling, M. E., & Kohn, D. F. (1997) · ILAR Journal · doi:10.1093/ilar.38.1.41 · Cited by 4,417
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050 · cited 4×
“…the concordance between preclinical animal safety data and human clinical outcomes for 150 development compounds and found that hepatotoxicity ( 60% concordance) and cutaneous/hypersensitivity reactions ( 40% concordance) were the 2 poorest predicted adverse events (Olson et al., 2000).”
BackgroundInfluentialBile salt transporters: molecular characterization, function, and regulation
Trauner, M., & Boyer, J. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00027.2002 · Cited by 999
Stepan, A. F., Walker, D. P., Bauman, J., Price, D. A., Baillie, T. A., Kalgutkar, A. S., & Aleo, M. D. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200168d · Cited by 698
Stieger, B., Fattinger, K., Madon, J., Kullak-Ublick, G. A., & Meier, P. J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70224-1 · Cited by 582
Fattinger, K. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.114667 · Cited by 509
The apical conjugate efflux pump ABCC2 (MRP2)
Nies, A. T., & Keppler, D. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0109-y · Cited by 398
Dawson, S., Stahl, S., Paul, N., Barber, J., & Kenna, J. G. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040758 · Cited by 343
Zollner, G., Marschall, H.-U., Wagner, M., & Trauner, M. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060010s · Cited by 335
Morgan, R. E., Trauner, M., van Staden, C. J., Lee, P. H., Ramachandran, B., Eschenberg, M., Afshari, C. A., Qualls, C. W., Lightfoot-Dunn, R., & Hamadeh, H. K. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq269 · Cited by 325
Self-citationMultidrug Resistance Proteins (MRPs, ABCCs): Importance for Pathophysiology and Drug Therapy
Keppler, D. (2011) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-14541-4_8 · Cited by 318
Zhou, S.-F., Wang, L.-L., Di, Y., Xue, C., Duan, W., Li, C., & Li, Y. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785132870 · Cited by 318
The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA Perspective
Bjornsson, T. D., Callaghan, J. T., Einolf, H. J., Fischer, V., Gan, L., Grimm, S., Kao, J., King, S. P., Miwa, G., Ni, L., et al. (2003) · Journal of Clinical Pharmacology · doi:10.1177/0091270003043005001 · Cited by 315
Funk, C., Ponelle, C., Scheuermann, G., & Pantze, M. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12255-9 · Cited by 296
Mechanisms of drug-induced liver injury: from bedside to bench
Tujios, S., & Fontana, R. J. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.22 · Cited by 277
Stieger, B., Meier, Y., & Meier, P. J. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0152-8 · Cited by 235
Mitochondrially-mediated toxicity of bile acids
Palmeira, C. M., & Rolo, A. P. (2004) · Toxicology · doi:10.1016/j.tox.2004.06.001 · Cited by 206
The bile salt export pump (BSEP) in health and disease
Kubitz, R., Dröge, C., Stindt, J., Weissenberger, K., & Häussinger, D. (2012) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2012.06.006 · Cited by 186
Role of the bile salt export pump, BSEP, in acquired forms of cholestasis
Stieger, B. (2009) · Drug Metabolism Reviews · doi:10.3109/03602530903492004 · Cited by 146
Kostrubsky, V. E., Strom, S. C., Hanson, J., Urda, E., Rose, K., Burliegh, J., Zocharski, P., Cai, H., Sinclair, J. F., & Sahi, J. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg217 · Cited by 138
Metabolic and Non-Metabolic Factors Determining Troglitazone Hepatotoxicity: A Review
Masubuchi, Y. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.347 · Cited by 132
Pedersen, J. M., Matsson, P., Bergström, C. A. S., Norinder, U., Hoogstraate, J. A., & Artursson, P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7015683 · Cited by 131
Gene Expression Changes Induced by PPAR Gamma Agonists in Animal and Human Liver
Rogue, A., Spire, C., Brun, M., Claude, N., & Guillouzo, A. (2010) · PPAR Research · doi:10.1155/2010/325183 · Cited by 127
Kostrubsky, S. E., Strom, S. C., Kalgutkar, A. S. S., Kulkarni, S., Atherton, J., Mireles, R. J., Feng, B., Kubik, R., Hanson, J., Urda, E. R., et al. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj095 · Cited by 121
Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity
Zollner, G., Wagner, M., & Trauner, M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.03.005 · Cited by 96
Li, F., Patterson, A. D., Krausz, K. W., Tanaka, N., & Gonzalez, F. J. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m027433 · Cited by 85
Drug-Induced Liver Injury: Past, Present and Future
Daly, A. K. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.24 · Cited by 80
Feng, B., Xu, J. J., Bi, Y.-A., Mireles, R., Davidson, R., Duignan, D. B., Campbell, S., Kostrubsky, V. E., Dunn, M. C., Smith, A. R., et al. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp033 · Cited by 80
Rolo, A. P. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh078 · Cited by 76
Current Challenges and Controversies in Drug-Induced Liver Injury
Corsini, A., Ganey, P. E., Ju, C., Kaplowitz, N., Pessayre, D., Roth, R. A., Watkins, P. B., Albassam, M., Liu, B., Stancic, S., et al. (2012) · Drug Safety · doi:10.1007/bf03261997 · Cited by 63
The primary role of hepatic metabolism in idiosyncratic drug-induced liver injury
Amacher, D. E. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.658041 · Cited by 58
Drug-induced liver injury: a summary of recent advances
Stine, J. G., & Lewis, J. H. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.577415 · Cited by 58
Mitochondrially mediated synergistic cell killing by bile acids
Rolo, A. P., Palmeira, C. M., & Wallace, K. B. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00224-7 · Cited by 55
Current Challenges and Controversies in Drug-Induced Liver Injury
Corsini, A., Ganey, P. E., Ju, C., et al. (2012) · Drug Safety · doi:10.2165/11632970-000000000-00000 · Cited by 50
Cholestasis and the Role of Basolateral Efflux Pumps
KEPPLER, D. O. R. (2011) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0031-1281755 · Cited by 47
Herédi‐Szabó, K., Kis, E., Molnar, E. M., András, G., & Krajcsi, P. (2008) · SLAS DISCOVERY · doi:10.1177/1087057108316702 · Cited by 44
Lundell, K., & Wikvall, K. (2008) · Current Drug Metabolism · doi:10.2174/138920008784220574 · Cited by 33
Gerk, P. M., Li, W., & Vore, M. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000372 · Cited by 28
Membrane Vesicle ABC Transporter Assays for Drug Safety Assessment
van Staden, C. J., Morgan, R. E., Ramachandran, B., Chen, Y., Lee, P. H., & Hamadeh, H. K. (2012) · Current Protocols in Toxicology · doi:10.1002/0471140856.tx2305s54 · Cited by 25
Self-citationLétourneau, I. J., Bowers, R. J., Deeley, R. G., & Cole, S. P. C. (2005) · Toxicology Letters · doi:10.1016/j.toxlet.2004.12.014 · Cited by 24
Hamadeh, H. K., Todd, M. D., Healy, L. N., Meyer, J. T., Kwok, A. M., Higgins, M. A., & Afshari, C. A. (2010) · Chemical Research in Toxicology · doi:10.1021/tx1000333 · Cited by 17
Self-citation
Cited by
Mechanistic diversity in ATP-binding cassette (ABC) transporters.
Locher, K. P. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3216 · Cited by 804
Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury
Proctor, W. R., Foster, A. J., Vogt, J., Summers, C., Middleton, B., Pilling, M. A., Shienson, D., Kijanska, M., Ströbel, S., Kelm, J. M., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2002-1 · Cited by 328
“2016), AMG-009 (Morgan et al. 2013), and TAK-875 (Wolenski et al.”
BackgroundInfluentialBindingDB in 2024: a FAIR knowledgebase of protein-small molecule binding data
Liu, T., Hwang, L., Burley, S. K., Nitsche, C. I., Southan, C., Walters, W. P., & Gilson, M. K. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkae1075 · Cited by 236
“…(SAR) for a given protein target ( 28 ); reports of new data for many compounds against a panel of kinases ( 29 ); large ADME-related studies ( 30 ,31 ); publications associated with datasets within the PDSP database ( 32 ,33 ); and review articles or articles with large datasets assembled…”
Zamek‐Gliszczynski, M. J., Taub, M. E., Chothe, P. P., Chu, X., Giacomini, K. M., Kim, R. B., Ray, A. S., Stocker, S. L., Unadkat, J. D., Wittwer, M. B., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1112 · Cited by 231
Renal Drug Transporters and Drug Interactions
Ivanyuk, A., Livio, F., Biollaz, J., & Buclin, T. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0506-8 · Cited by 221
Metadata
- Authors
- Morgan, R. E., van Staden, C. J., Chen, Y., Kalyanaraman, N., Kalanzi, J., Dunn, R. T., Afshari, C. A., & Hamadeh, H. K.
- Affiliations
- Amgen (United States) (US)
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-08-16
- Volume
- 136
- Issue
- 1
- Pages
- 216-241
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2152548885
- Cited by
- 243
- References
- 41
- Citations by year
- 2026: 12 · 2025: 19 · 2024: 14 · 2023: 14 · 2022: 15 · 2021: 13 · 2020: 12 · 2019: 24 · 2018: 20 · 2017: 33 · 2016: 30 · 2015: 24 · 2014: 11 · 2013: 2
- FWCI
- 11.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Toxicological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- bile salt export pump, drug-induced liver injury, hepatotoxicity, bile acid transport, multidrug resistance-associated protein, MRP2, MRP3, MRP4, steady-state concentration, hepatobiliary transporters, drug safety assessment
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily B, Member 11, Animals, Biological Transport, Humans, Liver, Male, Pharmacokinetics, Recombinant Proteins, Risk Factors, Cluster Analysis, Rats, Sprague-Dawley, ATP Binding Cassette Transporter, Subfamily B, ATP-Binding Cassette Transporters, Risk Assessment, Toxicity Tests, ATP-Binding Cassette, Sub-Family C Proteins, Rats, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.